Sep 2026 · Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Sep - PCBL Chemical will participate in PL Capital Investor Conference on 29 September 2026 in Mumbai.
Source: Bse
Chemicals stocks · Large cap · NSE
PCBL Chemical Limited manufactures carbon black, a key ingredient for the tyre and non-tyre industries, and operates a specialty chemicals business (Aquapharm) focusing on water solutions, home care, and oil & gas. The company is also diversifying into battery chemicals through its Nanovace platform.
MACD − · sector -4.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +17.0% · PAT +64.9% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +17% YoY · PAT +65% YoY · margin expansion · +20% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹2,473 Cr | +17.0% | +19.7% |
| EBITDA | ₹396 Cr | +24.1% | +63.0% |
| Operating margin | 16.0% | +100 bps | +400 bps |
| PAT | ₹155 Cr | +64.9% | +287.5% |
| PAT margin | 6.3% | +182 bps | +433 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term uptrend intact. RSI 34.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 28 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +1 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 FY26 Carbon Black Volumes Up YoY, But Margins Pressured by West Asia Conflict & Input Costs; Aquapharm Faces Headwinds.
The company navigated significant Q4 FY26 headwinds from the West Asia conflict, crude volatility, and logistics costs, impacting margins and Aquapharm's performance. However, management highlights clear recovery signals, including US tariff rationalization, India-EU FTA, customer restocking, and cost initiatives, projecting double-digit EBITDA growth for FY27.
Specialty sales volumes grew by 26% YoY to 19,386 tons in Q4 FY26. Management is selectively increasing focus and resource reallocation in this segment.
Pilot plant at Palej is fully equipped and ready for commissioning within weeks. Engagement with large battery manufacturers is underway to validate product properties.
India-EU FTA opens duty-free access to 1.8 million tons carbon black market. Recent U.S. tariff reduction restores cost advantage for Indian exports, seeing good traction from US customers.
Program is progressing well, on track to unlock over INR 200-250 crores of savings over the next 4-6 quarters through yield improvement, throughput enhancement, and feedstock diversification.
Added 90,000 tons of carbon black capacity (Brownfield expansion at Tamil Nadu), bringing total installed capacity to 880,000 tons per annum.
1,000 MTPA line at Palej, Gujarat, is mechanically ready for commissioning, but delayed due to gas shortage.
20,000 tons line in Mudra is ready and will be commissioned in the next few weeks.
Successfully expanded capacity from 130,000 tons to 167,000 tons during the year.
Broad industry dynamics show clear signs of recovery; spreads appear to have found a floor, and exit quarter momentum has turned positive.
Recent rationalization of U.S. tariffs restored a meaningful cost advantage for Indian exports. India-EU FTA opens duty-free access to a significant carbon black market.
Customers are shifting from just-in-time to a 'just-in-case' approach, building strategic inventory buffers, which is translating into incremental demand.
The Indian tyre sector in FY27 is poised for robust, high single-digit growth, supported by high vehicle usage and aging commercial vehicle fleet.
Escalation of West Asia conflict created significant disruptions, massive increases in logistics cost, cost of feedstock, and availability of ships.
Raw material prices (linked to crude) rose sharply; Brent started at $60, ended March at $100, and is hovering close to $120 per barrel.
Formula-based contracts with tyre majors carry an inherent quarterly lag effect, meaning the full impact of cost pass-through will reflect in Q2 FY27.
Aquapharm faced 25-30% rise in raw material prices (yellow phosphorus, acrylic acid, malic acid), increased lead times, and freight rates due to West Asia conflict.
Ongoing West Asia conflict continues to pose risks to global supply chains, logistics, and raw material costs, impacting profitability.
Raw material prices are directly linked to crude, and continued high volatility can exert significant pressure on margins.
Surplus domestic capacity in the carbon black industry persisted through Q4 FY26, potentially limiting pricing power.
Battery chemicals (Nanovace) require a validation period of a few months post-commissioning before capacity ramp-up begins.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is relevant for assessing overall growth and the impact of annual trends. QoQ is crucial for understanding sequential momentum, especially given the stated lag effect of cost pass-through in contracts and the expected recovery consolidation over the next 2-3 quarters.
Consolidated sales volume increased by 8% YoY to 161,865 MT. Domestic sales volume grew by 21% YoY to 105,055 tons, while international sales volume decreased by 10% to 56,800 tons.
Sales volume for carbon black decreased 4% YoY to 618,956 metric tons in FY26 (vs 596,262 metric tons in FY25).
Consolidated EBITDA were INR 248 crores.
Consolidated EBITDA for FY26 stood at INR 1,081 crores as against INR 1,384 crores in FY25.
Confident of delivering double-digit EBITDA growth in FY27, fueled by volume momentum, leaner cost structure, and better pricing realization.
Maintaining capital discipline with investment priorities towards specialty carbon black, battery chemicals, and other value-added segments.
Goal remains to reach INR 75 crores per quarter EBITDA run rate for Aquapharm over the next 2-3 quarters.
The long-term fundamentals remain intact, and the INR 40 billion EBITDA guidance by 2030 remains on track.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Carbon Black EBITDA per ton | Q4 FY26 EBITDA per ton not explicitly stated, but management noted it did not improve much QoQ. | Strong double-digit increase in EBITDA per ton for FY27, driven by pricing, product mix, and cost initiatives. |
| Aquapharm Quarterly EBITDA | INR 29 crores in Q4 FY26. | Achievement of INR 75 crores per quarter EBITDA run rate within the next 2-3 quarters. |
| Nanovace (Battery Chemicals) Progress | Pilot plant ready for commissioning; product validation with large battery manufacturers underway. | Successful product qualification and commencement of commercial volumes, expected in FY28. |
| Cost Savings Realization | Program progressing well. | Realization of INR 200-250 crores of savings over the next 4-6 quarters from yield, throughput, and feedstock diversification. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 20th percentile of the scored universe and 15th percentile within Chemicals. Main check: financial discipline is weak at 18/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 15th pctile, median 73 · Large: 11th pctile, median 73
77 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Company Ir
Source: Bse